U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT05096182) titled 'Long-term Follow-up of Patients With Chronic Kidney Disease Who Had Administered Cellgram-CKD in PMC-P-12 Study' on Oct. 15.
Brief Summary: This long-term follow-up study is a 5-year long-term follow-up study to evaluate long-term safety in Cellgram-CKD subjects. (refer to ClinicalTrials.gov.Identifier: NCT05042206).
Study Type: Observational
Condition: Renal Insufficiency, Chronic
Recruitment Status: Not Yet Recruiting
Sponsor: Pharmicell Co., Ltd.
Information provided by (Responsible Party): Pharmicell Co., Ltd.
Published by HT Digital Content Services with permission from Health Daily Digest....